Curve Therapeutics Raises £40.5 million to Turbocharge Discovery Platform and Advance Breakthrough Pipeline
February 27, 2024
Southampton, UK – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets,